[Acquired hemophilia A that developed after BNT162b2 mRNA COVID-19 vaccination and worsened following re-vaccination].

Sorimachi, Momoka; Ogawa, Yoshiyuki; Matsumoto, Akira; Souri, Masayoshi; Koitabashi, Rumiko; Kajita, Mikiya; Akashi, Naoki; Naito, Chiaki; Ishikawa, Tetsuya; Kobayashi, Nobuhiko; Miyazawa, Yuri; Ichinose, Akitada; Handa, Hiroshi

Sorimachi, Momoka; Ogawa, Yoshiyuki; Matsumoto, Akira; Souri, Masayoshi; Koitabashi, Rumiko; Kajita, Mikiya; Akashi, Naoki; Naito, Chiaki; Ishikawa, Tetsuya; Kobayashi, Nobuhiko; Miyazawa, Yuri; Ichinose, Akitada; Handa, Hiroshi.

Afiliação

Sorimachi M; Department of Hematology, Gunma University Graduate School of Medicine.
Ogawa Y; Department of Hematology, Gunma University Graduate School of Medicine.
Matsumoto A; Department of Hematology, Gunma University Graduate School of Medicine.
Souri M; Department of Public Health and Hygiene, Yamagata University Faculty of Medicine.
Koitabashi R; Department of Hematology, Gunma University Graduate School of Medicine.
Kajita M; Department of Hematology, Gunma University Graduate School of Medicine.
Akashi N; Department of Hematology, Gunma University Graduate School of Medicine.
Naito C; Department of Hematology, Gunma University Graduate School of Medicine.
Ishikawa T; Department of Hematology, Gunma University Graduate School of Medicine.
Kobayashi N; Department of Hematology, Gunma University Graduate School of Medicine.
Miyazawa Y; Department of Hematology, Gunma University Graduate School of Medicine.
Ichinose A; Faculty of Medicine, Yamagata University.
Handa H; Department of Hematology, Gunma University Graduate School of Medicine.

Rinsho Ketsueki ; 64(1): 60-65, 2023.

Article em Ja | MEDLINE | ID: mdl-36775309

Assuntos

Vacina BNT162; COVID-19; Hemofilia A; Hemostáticos; Idoso de 80 Anos ou mais; Humanos; Masculino; Atividades Cotidianas; Vacina BNT162/efeitos adversos; COVID-19/prevenção & controle; Fator VIII/uso terapêutico; Hemofilia A/induzido quimicamente; Hemofilia A/terapia; Hemostáticos/uso terapêutico; Prednisolona/uso terapêutico

Palavras-chave

Acquired hemophilia A (AHA); COVID-19; SARS-CoV-2 vaccine; Vaccination

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hemostáticos / COVID-19 / Vacina BNT162 / Hemofilia A Limite: Aged80 / Humans / Male Idioma: Ja Revista: Rinsho Ketsueki Ano de publicação: 2023 Tipo de documento: Article País de publicação: Japão

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google